"10.1371_journal.pone.0147995","plos one","2016-01-25T00:00:00Z","David B Shultz; Jonathan Pai; Wayland Chiu; Kendall Ng; Madeline G Hellendag; Gregory Heestand; Daniel T Chang; Dongsheng Tu; Malcolm J Moore; Wendy R Parulekar; Albert C Koong","Princess Margaret Cancer Centre, Toronto, Ontario, Canada; School of Medicine, University of California San Francisco, San Francisco, United States of America; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States of America; Kaiser Permanente Medical Center, San Francisco, United States of America; Moores Cancer Center, University of California San Diego, La Jolla, CA, United States of America; NCIC Clinical Trials Group, Queens University, Kingston, Canada; British Columbia Cancer Agency, Vancouver, British Columbia, CA, United States of America","Conceived and designed the experiments: DS WP AK. Performed the experiments: JP WC KN MH GH DT. Analyzed the data: DS JP WC KN MH DT WP AK. Contributed reagents/materials/analysis tools: MH GH MM WP AK. Wrote the paper: DS DC AK.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: GH has served as a consultant for Bayer, Merrimack, and Genomic Health. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","01","David B Shultz","DBS",11,TRUE,3,6,8,3,TRUE,TRUE,FALSE,0,NA,FALSE
